Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease

Machado–Joseph disease (MJD) is the most common dominantly-inherited ataxia worldwide with no effective treatment to prevent, stop or alleviate its progression. Neuropeptide Y (NPY) is a neuroprotective agent widely expressed in the mammalian brain. Our previous work showed that NPY overexpression m...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte-Neves, Joana, Cavadas, Cláudia, Pereira de Almeida, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870889/
https://www.ncbi.nlm.nih.gov/pubmed/33558582
http://dx.doi.org/10.1038/s41598-021-82339-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870889/
https://www.ncbi.nlm.nih.gov/pubmed/33558582
http://dx.doi.org/10.1038/s41598-021-82339-5

Ejemplares similares